Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study

• Autores principales: Yong-Shuai Wang (Autor), Wei Wang (Autor), Sai Zhang (Autor), Shen-Yu Zhang (Autor), Ai-Zong Shen (Autor), Hua-Chuan Song (Autor), Huan-Zhang Yao (Autor), Rui-Peng Song (Autor), Fan-Zheng Meng (Autor), Lei Li (Autor), Bjoern Nashan (Autor), Ji-Zhou Wang (Autor), Lian-Xin Liu (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Purpose: To investigate the clinical efficacy of avatrombopag, an oral thrombopoietin receptor agonist, versus subcutaneous recombinant human thrombopoietin (rh-TPO) in the treatment of severe thrombocytopenia (TCP) associated with chronic liver disease (CLD).Methods: Clinical data of 250 patients w...